1. Home
  2. CURR vs OSTX Comparison

CURR vs OSTX Comparison

Compare CURR & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CURR
  • OSTX
  • Stock Information
  • Founded
  • CURR 2013
  • OSTX 2018
  • Country
  • CURR Singapore
  • OSTX United States
  • Employees
  • CURR N/A
  • OSTX N/A
  • Industry
  • CURR Business Services
  • OSTX
  • Sector
  • CURR Consumer Discretionary
  • OSTX
  • Exchange
  • CURR Nasdaq
  • OSTX NYSE
  • Market Cap
  • CURR 89.8M
  • OSTX 86.5M
  • IPO Year
  • CURR N/A
  • OSTX 2024
  • Fundamental
  • Price
  • CURR $1.92
  • OSTX $2.25
  • Analyst Decision
  • CURR
  • OSTX Strong Buy
  • Analyst Count
  • CURR 0
  • OSTX 1
  • Target Price
  • CURR N/A
  • OSTX $21.00
  • AVG Volume (30 Days)
  • CURR 10.1K
  • OSTX 19.7K
  • Earning Date
  • CURR 11-26-2024
  • OSTX 11-26-2024
  • Dividend Yield
  • CURR N/A
  • OSTX N/A
  • EPS Growth
  • CURR N/A
  • OSTX N/A
  • EPS
  • CURR N/A
  • OSTX N/A
  • Revenue
  • CURR N/A
  • OSTX N/A
  • Revenue This Year
  • CURR N/A
  • OSTX N/A
  • Revenue Next Year
  • CURR N/A
  • OSTX $9,900.00
  • P/E Ratio
  • CURR N/A
  • OSTX N/A
  • Revenue Growth
  • CURR N/A
  • OSTX N/A
  • 52 Week Low
  • CURR $1.70
  • OSTX $2.10
  • 52 Week High
  • CURR $5.74
  • OSTX $4.90
  • Technical
  • Relative Strength Index (RSI)
  • CURR N/A
  • OSTX N/A
  • Support Level
  • CURR N/A
  • OSTX N/A
  • Resistance Level
  • CURR N/A
  • OSTX N/A
  • Average True Range (ATR)
  • CURR 0.00
  • OSTX 0.00
  • MACD
  • CURR 0.00
  • OSTX 0.00
  • Stochastic Oscillator
  • CURR 0.00
  • OSTX 0.00

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants worldwide, delivering frictionless interoperable real-time fund transfers and instant messaging.

About OSTX OS THERAPIES INCORPORATED

OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.

Share on Social Networks: